MX2010001303A - Compuestos terapeuticos. - Google Patents

Compuestos terapeuticos.

Info

Publication number
MX2010001303A
MX2010001303A MX2010001303A MX2010001303A MX2010001303A MX 2010001303 A MX2010001303 A MX 2010001303A MX 2010001303 A MX2010001303 A MX 2010001303A MX 2010001303 A MX2010001303 A MX 2010001303A MX 2010001303 A MX2010001303 A MX 2010001303A
Authority
MX
Mexico
Prior art keywords
therapeutic compounds
compounds
salts
iii
activity
Prior art date
Application number
MX2010001303A
Other languages
English (en)
Spanish (es)
Inventor
Edmond J Lavoie
Joseph E Rice
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of MX2010001303A publication Critical patent/MX2010001303A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2010001303A 2007-08-02 2008-08-01 Compuestos terapeuticos. MX2010001303A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95364807P 2007-08-02 2007-08-02
PCT/US2008/072025 WO2009018551A2 (en) 2007-08-02 2008-08-01 Therapeutic compounds

Publications (1)

Publication Number Publication Date
MX2010001303A true MX2010001303A (es) 2010-09-07

Family

ID=40305296

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001303A MX2010001303A (es) 2007-08-02 2008-08-01 Compuestos terapeuticos.

Country Status (5)

Country Link
US (1) US8993607B2 (enExample)
EP (1) EP2185568A4 (enExample)
JP (1) JP2010535204A (enExample)
MX (1) MX2010001303A (enExample)
WO (1) WO2009018551A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093235B2 (en) 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
MX2010001304A (es) 2007-08-02 2010-09-07 Univ Rutgers Compuestos terapeuticos.
EP2185568A4 (en) 2007-08-02 2010-08-11 Trustees Rutgers The State Uni THERAPEUTIC COMPOUNDS
EP2496704A4 (en) * 2009-11-05 2013-05-01 Univ Rutgers THERAPEUTIC COMPOUNDS
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2020017624A1 (ja) * 2018-07-20 2020-01-23 国立大学法人東京農工大学 抗がん剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851524A (en) 1976-09-24 1989-07-25 Exxon Research And Engineering Company Amine-treated thio-bis-(alkyl lactone acid) and thio-bis-(hydrocarbyl diacid) materials, additives for lubricating compositions
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5869650A (en) 1996-06-21 1999-02-09 Fox Chase Cancer Center Dendroamide compounds and their use in chemosensitizing multidrug resistant cells
JPH11180997A (ja) * 1997-12-24 1999-07-06 Yamanouchi Pharmaceut Co Ltd 新規抗腫瘍化合物
AU2260402A (en) 2000-12-12 2002-06-24 Taiho Pharmaceutical Co Ltd Process for preparing substance gm-95
JPWO2004078764A1 (ja) 2003-03-04 2006-06-08 株式会社そーせい Ｇｍ−９５物質を含む抗腫瘍効果増強剤、抗腫瘍用組み合わせ製剤及び抗腫瘍剤
GB0314726D0 (en) 2003-06-24 2003-07-30 Inst Biomar Sa New cytotoxic depsipeptides
JP2006160723A (ja) * 2004-11-10 2006-06-22 Marine Biotechnol Inst Co Ltd 抗腫瘍活性を有する化合物及びその製造方法
JP4876220B2 (ja) 2005-05-13 2012-02-15 国立大学法人東京農工大学 テロメスタチン誘導体
US8093235B2 (en) 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
CA2665818A1 (en) 2006-04-25 2007-11-08 Rutgers, The State University Of New Jersey Therapeutic compounds
MX2010001304A (es) 2007-08-02 2010-09-07 Univ Rutgers Compuestos terapeuticos.
EP2185568A4 (en) 2007-08-02 2010-08-11 Trustees Rutgers The State Uni THERAPEUTIC COMPOUNDS
EP2186810A1 (en) 2008-10-31 2010-05-19 Institut Curie Poly-heteroaryl derivatives for the treatment of cancer
EP2496704A4 (en) 2009-11-05 2013-05-01 Univ Rutgers THERAPEUTIC COMPOUNDS

Also Published As

Publication number Publication date
EP2185568A2 (en) 2010-05-19
US20120046234A1 (en) 2012-02-23
JP2010535204A (ja) 2010-11-18
WO2009018551A2 (en) 2009-02-05
EP2185568A4 (en) 2010-08-11
US8993607B2 (en) 2015-03-31
WO2009018551A3 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
MX2009011211A (es) Indoles sustituidos en la posicion 7 inhibidores de mci-1.
EA201170872A1 (ru) Ингибиторы протеинкиназы
EA201170521A1 (ru) Новые соединения
MX2009011210A (es) Inhibidores de mcl1 de indol 7-no sustituido.
TW200740435A (en) Therapeutic agent for diabetes
IN2012DN00869A (enExample)
TW200744586A (en) Therapeutic compounds
SG178591A1 (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
MY153915A (en) Organic compounds
TW200942533A (en) Pyridyl inhibitors of hedgehog signalling
JO2872B1 (en) New vehicles
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MY145795A (en) Pyrazoline compounds
MX2011008289A (es) Tabletas para terapia combinada.
EA201170344A1 (ru) Азаиндольные ингибиторы iap
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
MX2010001303A (es) Compuestos terapeuticos.
MX2009009490A (es) Profarmacos novedosos.
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
EA201000069A1 (ru) Новые гербициды
TR201818771T4 (tr) Bilişsel Bozuklukların Tedavisinde Kullanıma Yönelik Bileşikler
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MX2010001304A (es) Compuestos terapeuticos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal